A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
Voorhees, Peter M., Manges, Robert F., Sonneveld, Pieter, Jagannath, Sundar, Somlo, George, Krishnan, Amrita, Lentzsch, Suzanne, Frank, Richard C., Zweegman, Sonja, Wijermans, Pierre W., Orlowski, RobVolume:
161
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.12266
Date:
May, 2013
File:
PDF, 164 KB
english, 2013